Clinical Focus
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer
2
RFS Benefit Sustained at 5 Years for Intismeran Autogene in Melanoma
3
Epcoritamab Monotherapy Yields Positive Results in Phase 3 R/R DLBCL Trial
4
FDA Grants BTD to Sofetabart Mipitecan for Platinum-Resistant Ovarian Cancer
5